| Ms Shannon C Fife, DO | |
|
940 Royal Ave, Suite 350, Medford, OR 97504-6193 | |
| (541) 732-7460 | |
| (541) 732-7461 |
| Full Name | Ms Shannon C Fife |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 22 Years |
| Location | 940 Royal Ave, Medford, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639282148 | NPI | - | NPPES |
| 005986 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | DO26604 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Medford Medical Center | Medford, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 5294623245 | 159 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Along with supply and equipment cargo bound for the International Space Station, Space Shuttle Discovery STS-128 will carry an additional scientific payload being conducted by Austin-based Astrogenetix, the first commercial space company to use microgravity to discover the foundation of new medicines.
A rare hereditary disorder that strongly predisposes carriers to develop cancer at an early age has been found in an Asian female, report researchers at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine.
New research from Western University (London, Canada) is leading to a better understanding of what happens during heart failure; knowledge that could lead to better therapeutics or a more accurate predictor of risk.
› Verified 9 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093976243 PECOS PAC ID: 3476450560 Enrollment ID: O20031217000186 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Along with supply and equipment cargo bound for the International Space Station, Space Shuttle Discovery STS-128 will carry an additional scientific payload being conducted by Austin-based Astrogenetix, the first commercial space company to use microgravity to discover the foundation of new medicines.
A rare hereditary disorder that strongly predisposes carriers to develop cancer at an early age has been found in an Asian female, report researchers at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine.
New research from Western University (London, Canada) is leading to a better understanding of what happens during heart failure; knowledge that could lead to better therapeutics or a more accurate predictor of risk.
› Verified 9 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568547503 PECOS PAC ID: 5294623245 Enrollment ID: O20040310000315 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Along with supply and equipment cargo bound for the International Space Station, Space Shuttle Discovery STS-128 will carry an additional scientific payload being conducted by Austin-based Astrogenetix, the first commercial space company to use microgravity to discover the foundation of new medicines.
A rare hereditary disorder that strongly predisposes carriers to develop cancer at an early age has been found in an Asian female, report researchers at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine.
New research from Western University (London, Canada) is leading to a better understanding of what happens during heart failure; knowledge that could lead to better therapeutics or a more accurate predictor of risk.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Shannon C Fife, DO Po Box 3158, Portland, OR 97208-3158 Ph: (503) 215-6494 | Ms Shannon C Fife, DO 940 Royal Ave, Suite 350, Medford, OR 97504-6193 Ph: (541) 732-7460 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Along with supply and equipment cargo bound for the International Space Station, Space Shuttle Discovery STS-128 will carry an additional scientific payload being conducted by Austin-based Astrogenetix, the first commercial space company to use microgravity to discover the foundation of new medicines.
A rare hereditary disorder that strongly predisposes carriers to develop cancer at an early age has been found in an Asian female, report researchers at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine.
New research from Western University (London, Canada) is leading to a better understanding of what happens during heart failure; knowledge that could lead to better therapeutics or a more accurate predictor of risk.
› Verified 9 days ago
Anthony Eugene Ramsey, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 691 Murphy Road, Suite #202, Medford, OR 97504 Phone: 541-734-7733 Fax: 541-734-7744 | |
Dr. Daniel Alan Tomlinson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 3170 State St, Medford, OR 97504 Phone: 541-864-8900 Fax: 541-245-3315 | |
Ms. Carissa Marie Ross, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3170 State St, Medford, OR 97504 Phone: 541-864-8900 Fax: 541-245-3315 | |
Daniel Albert Kahn, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2911 Siskiyou Blvd, Medford, OR 97504 Phone: 541-789-5982 Fax: 541-789-5983 | |
Timothy B Hutchings, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 940 Royal Ave, Ste 350, Medford, OR 97504 Phone: 541-732-7460 Fax: 541-732-7461 | |
Lorie Jane Morgan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2859 State St, Suite 102, Medford, OR 97504 Phone: 541-282-6518 Fax: 541-282-6510 | |
Jennifer Veit Hall Jackson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 940 Royal Ave Unit 350, Medford, OR 97504 Phone: 541-732-7460 |